Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Virios Therapeutics Inc (NQ: VIRI ) 0.2200 -0.0100 (-4.35%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Virios Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > Virios Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on Thursday, May 12, 2022 May 05, 2022 From Virios Therapeutics, Inc. Via Business Wire Virios Therapeutics Completes Enrollment of 425 Patients in Phase 2b “FORTRESS” Clinical Trial for Fibromyalgia April 28, 2022 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Earnings Scheduled For November 11, 2021 November 11, 2021 Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... Via Benzinga The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety Virios Therapeutics: Q4 Earnings Insights March 17, 2022 Virios Therapeutics (NASDAQ:VIRI) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update March 17, 2022 From Virios Therapeutics, Inc. Via Business Wire A Preview Of Virios Therapeutics's Earnings March 16, 2022 Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... Via Benzinga Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID February 28, 2022 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Earnings Scheduled For March 17, 2022 March 17, 2022 Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... Via Benzinga An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease? February 02, 2022 Photo by Fusion Medical Animation on Unsplash Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. (NASDAQ: VIRI), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022. Via Benzinga Benzinga Announces This Week's All Access Guests January 27, 2022 Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am:... Via Benzinga RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28 January 26, 2022 ORLANDO, FL / ACCESSWIRE / January 26, 2022 / RedChip Companies, Inc., an international investor relations, media, and research firm focused on microcap and small-cap companies, is pleased to announce... From RedChip Via AccessWire Virios Therapeutics to Present at the Virtual H.C. Wainwright BioConnect Conference January 04, 2022 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 December 15, 2021 Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: Via Benzinga Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia December 01, 2021 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update November 11, 2021 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021 November 04, 2021 From Virios Therapeutics, Inc. (VIRI) Via Business Wire 64 Biggest Movers From Yesterday November 02, 2021 Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... Via Benzinga Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination September 08, 2021 From Virios Therapeutics, Inc. Via Business Wire Virios Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 02, 2021 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Stocks That Hit 52-Week Lows On Friday August 20, 2021 On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... Via Benzinga Virios Therapeutics Announces New Social Media Profiles August 19, 2021 From Virios Therapeutics, Inc. Via Business Wire Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview August 16, 2021 From Virios Therapeutics, Inc. Via Business Wire Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update August 12, 2021 From Virios Therapeutics, Inc. Via Business Wire Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 August 16, 2021 LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... From Stock News Now Via AccessWire Topics Cannabis Exposures Cannabis The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety Earnings Scheduled For August 12, 2021 August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... Via Benzinga Virios Therapeutics to Present at the SNN Network Summer Virtual Conference August 11, 2021 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Virios Therapeutics Featured in Bloomberg TV Interview August 09, 2021 From Virios Therapeutics, Inc. (VIRI) Via Business Wire Virios Therapeutics to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Thursday, August 12, 2021 August 05, 2021 From Virios Therapeutics, Inc. (VIRI) Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.